Does RISANKIZUMAB-RZAA Cause Intestinal obstruction? 853 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 853 reports of Intestinal obstruction have been filed in association with RISANKIZUMAB-RZAA. This represents 1.3% of all adverse event reports for RISANKIZUMAB-RZAA.
853
Reports of Intestinal obstruction with RISANKIZUMAB-RZAA
1.3%
of all RISANKIZUMAB-RZAA reports
4
Deaths
570
Hospitalizations
How Dangerous Is Intestinal obstruction From RISANKIZUMAB-RZAA?
Of the 853 reports, 4 (0.5%) resulted in death, 570 (66.8%) required hospitalization, and 2 (0.2%) were considered life-threatening.
Is Intestinal obstruction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 853 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Intestinal obstruction?
ADALIMUMAB (5,727)
VEDOLIZUMAB (1,263)
SEMAGLUTIDE (924)
INFLIXIMAB (907)
BEVACIZUMAB (686)
LENALIDOMIDE (504)
CLOZAPINE (484)
OCTREOTIDE (463)
USTEKINUMAB (459)
INFLIXIMAB-DYYB (409)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Intestinal obstruction Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA